INTERNATIONAL PATENT: APEXIMMUNE THERAPEUTICS INC. FILES APPLICATION FOR "COMBINATION THERAPY COMPRISING ANTI-PLA2G2D ANTIBODIES AND USES THEREOF"

GENEVA, March 25 -- APEXIMMUNE THERAPEUTICS INC. (650 Gateway Boulevard, Suite 110South San Francisco, California 94080) filed a patent application (PCT/US2025/046360) for "COMBINATION THERAPY COMPRISING ANTI-PLA2G2D ANTIBODIES AND USES THEREOF" on Sep 15, 2025. With publication no. WO/2026/060351, the details related to the patent application was published on Mar 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LEE, Li-Fen (c/o Apeximmune Therapeutics Inc.650 Gateway Boulevard, Suite 110South San Francisco, California 94080), LU, Kan (c/o Apeximmune Therapeutics Inc.650 Gateway Boulevard...